NWMN2330 May Be Associated with the Virulence of Staphylococcus aureus by Increasing the Expression of hla and saeRS

References

• Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5(12):751–762. doi:10.1016/S1473-3099(05)70295-4
   PubMed Web of Science ®Google Scholar
• Rasigade JP, Dumitrescu O, Lina G. New epidemiology of Staphylococcus aureus infections. Clin Microbiol Infect. 2014;20(7):587–588. doi:10.1111/1469-0691.12718
   PubMed Web of Science ®Google Scholar
• Klevens RM, Morrison MA, Nadle J, et al. Active bacterial core surveillance MI. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763–1771. doi:10.1001/jama.298.15.1763
   PubMed Web of Science ®Google Scholar
• Turner NA, Sharma-Kuinkel BK, Maskarinec SA, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17(4):203–218. doi:10.1038/s41579-018-0147-4
   PubMed Web of Science ®Google Scholar
• Lowy FD. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest. 2003;111(9):1265–1273. doi:10.1172/JCI18535
   PubMed Web of Science ®Google Scholar
• Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547–569. doi:10.1080/21505594.2021.1878688
   PubMed Web of Science ®Google Scholar
• McGuinness WA, Malachowa N, DeLeo FR. Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med. 2017;90(2):269–281.
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Kayayama Y, Matsuo M, et al. Vancomycin-intermediate resistance in Staphylococcus aureus. J Glob Antimicrob Resist. 2014;2(4):213–224. doi:10.1016/j.jgar.2014.04.006
   PubMed Web of Science ®Google Scholar
• Miller LS, Fowler VG, Shukla SK, Rose WE, Proctor RA. Development of a vaccine against Staphylococcus aureus invasive infections: evidence based on human immunity, genetics and bacterial evasion mechanisms. FEMS Microbiol Rev. 2020;44(1):123–153. doi:10.1093/femsre/fuz030
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Bertholet S, Grandi G. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. Front Cell Infect Microbiol. 2012;2:16. doi:10.3389/fcimb.2012.00016
   PubMed Web of Science ®Google Scholar
• Cruz AR, van Strijp JAG, Bagnoli F, Manetti AGO. Virulence gene expression of Staphylococcus aureus in human skin. Front Microbiol. 2021;12:692023. doi:10.3389/fmicb.2021.692023
   Web of Science ®Google Scholar
• Hodille E, Rose W, Diep BA, Goutelle S, Lina G, Dumitrescu O. The role of antibiotics in modulating virulence in Staphylococcus aureus. Clin Microbiol Rev. 2017;30(4):887–917. doi:10.1128/CMR.00120-16
   PubMed Web of Science ®Google Scholar
• Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev. 2000;13(1):16–34, table of contents. doi:10.1128/CMR.13.1.16
   PubMed Web of Science ®Google Scholar
• Zhang B, Teng Z, Li X, et al. Chalcone attenuates Staphylococcus aureus virulence by targeting Sortase A and alpha-hemolysin. Front Microbiol. 2017;8:1715. doi:10.3389/fmicb.2017.01715
   PubMed Web of Science ®Google Scholar
• Teng Z, Shi D, Liu H, et al. Lysionotin attenuates Staphylococcus aureus pathogenicity by inhibiting alpha-toxin expression. Appl Microbiol Biotechnol. 2017;101(17):6697–6703. doi:10.1007/s00253-017-8417-z
   PubMed Web of Science ®Google Scholar
• Chen F, Di H, Wang Y, et al. Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence. Nat Chem Biol. 2016;12(3):174–179. doi:10.1038/nchembio.2003
   PubMed Web of Science ®Google Scholar
• Mu D, Xiang H, Dong H, Wang D, Wang T. Isovitexin, a potential candidate inhibitor of Sortase A of Staphylococcus aureus USA300. J Microbiol Biotechnol. 2018;28(9):1426–1432. doi:10.4014/jmb.1802.02014
   PubMed Web of Science ®Google Scholar
• Nitulescu G, Nicorescu IM, Olaru OT, et al. Molecular docking and screening studies of new natural Sortase A inhibitors. Int J Mol Sci. 2017;18(10):2217. doi:10.3390/ijms18102217
   Web of Science ®Google Scholar
• Duan J, Li M, Hao Z, et al. Subinhibitory concentrations of resveratrol reduce alpha-hemolysin production in Staphylococcus aureus isolates by downregulating saeRS. Emerg Microbes Infect. 2018;7(1):136. doi:10.1038/s41426-018-0142-x
   Web of Science ®Google Scholar
• Zhu Q, Wen W, Wang W, Sun B. Transcriptional regulation of virulence factors Spa and ClfB by the SpoVG-Rot cascade in Staphylococcus aureus. Int J Med Microbiol. 2019;309(1):39–53. doi:10.1016/j.ijmm.2018.10.006
   Web of Science ®Google Scholar
• Kaito C, Kurokawa K, Matsumoto Y, et al. Silkworm pathogenic bacteria infection model for identification of novel virulence genes. Mol Microbiol. 2005;56(4):934–944. doi:10.1111/j.1365-2958.2005.04596.x
   PubMed Web of Science ®Google Scholar
• Shang W, Rao Y, Zheng Y, et al. Beta-Lactam antibiotics enhance the pathogenicity of methicillin-resistant Staphylococcus aureus via SarA-controlled lipoprotein-like cluster expression. mBio. 2019;10(3). doi:10.1128/mBio.00880-19
   Web of Science ®Google Scholar
• McCaig LF, McDonald LC, Mandal S, Jernigan DB. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis. 2006;12(11):1715–1723. doi:10.3201/eid1211.060190
   PubMed Web of Science ®Google Scholar
• Moran GJ, Krishnadasan A, Gorwitz RJ, et al; Group EMINS. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355(7):666–674. doi:10.1056/NEJMoa055356
   PubMed Web of Science ®Google Scholar
• Nygaard TK, Pallister KB, Ruzevich P, Griffith S, Vuong C, Voyich JM. SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis. J Infect Dis. 2010;201(2):241–254. doi:10.1086/649570
   Web of Science ®Google Scholar
• Voyich JM, Vuong C, DeWald M, et al. The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J Infect Dis. 2009;199(11):1698–1706. doi:10.1086/598967
   PubMed Web of Science ®Google Scholar
• Watkins RL, Pallister KB, Voyich JM, Diep B. The SaeR/S gene regulatory system induces a pro-inflammatory cytokine response during Staphylococcus aureus infection. PLoS One. 2011;6(5):e19939. doi:10.1371/journal.pone.0019939
   Web of Science ®Google Scholar
• Montgomery CP, Daum RS. Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for panton-valentine leukocidin? Infect Immun. 2009;77(5):2159–2167. doi:10.1128/IAI.00021-09
   PubMed Web of Science ®Google Scholar
• Kong C, Neoh HM, Nathan S. Targeting Staphylococcus aureus toxins: a potential form of anti-virulence therapy. Toxins. 2016;8(3):72. doi:10.3390/toxins8030072
   Web of Science ®Google Scholar
• Sharifi A, Mohammadzadeh A, Salehi TZ, Mahmoodi P, Nourian A. Cuminum cyminum L. Essential Oil: a promising antibacterial and antivirulence agent against multidrug-resistant Staphylococcus aureus. Front Microbiol. 2021;12:667833. doi:10.3389/fmicb.2021.667833
   Web of Science ®Google Scholar
• Slavetinsky CJ, Hauser JN, Gekeler C, et al. Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF. Elife. 2022;11. doi:10.7554/eLife.66376
   Web of Science ®Google Scholar
• Zheng J, Shang Y, Wu Y, et al. Loratadine inhibits Staphylococcus aureus virulence and biofilm formation. iScience. 2022;25(2):103731. doi:10.1016/j.isci.2022.103731
   Web of Science ®Google Scholar
• Mi S, Tang Y, Dari G, et al. Transcriptome sequencing analysis for the identification of stable lncRNAs associated with bovine Staphylococcus aureus mastitis. J Anim Sci Biotechnol. 2021;12(1):120. doi:10.1186/s40104-021-00639-2
   Web of Science ®Google Scholar
• Slany M, Oppelt J, Cincarova L, Schaffner DW. Formation of Staphylococcus aureus Biofilm in the presence of sublethal concentrations of disinfectants studied via a transcriptomic analysis using transcriptome sequencing (RNA-seq). Appl Environ Microbiol. 2017;83(24):24. doi:10.1128/AEM.01643-17
   Web of Science ®Google Scholar
• Nygaard TK, Pallister KB, DuMont AL, et al. Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection. PLoS One. 2012;7(5):e36532. doi:10.1371/journal.pone.0036532
   PubMed Web of Science ®Google Scholar
• Shallcross LJ, Williams K, Hopkins S, Aldridge RW, Johnson AM, Hayward AC. Panton-Valentine leukocidin associated staphylococcal disease: a cross-sectional study at a London hospital, England. Clin Microbiol Infect. 2010;16(11):1644–1648. doi:10.1111/j.1469-0691.2010.03153.x
   PubMed Web of Science ®Google Scholar
• Seilie ES, Bubeck Wardenburg J. Staphylococcus aureus pore-forming toxins: the interface of pathogen and host complexity. Semin Cell Dev Biol. 2017;72:101–116. doi:10.1016/j.semcdb.2017.04.003
   PubMed Web of Science ®Google Scholar
• Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev. 1991;55(4):733–751. doi:10.1128/mr.55.4.733-751.1991
   PubMedGoogle Scholar
• Liu Q, Yeo WS, Bae T. The SaeRS two-component system of Staphylococcus aureus. Genes. 2016;7:10. doi:10.3390/genes7100081
   PubMed Web of Science ®Google Scholar
• Cheung AL, Ying P. Regulation of alpha- and beta-hemolysins by the sar locus of Staphylococcus aureus. J Bacteriol. 1994;176(3):580–585. doi:10.1128/jb.176.3.580-585.1994
   Web of Science ®Google Scholar